Warning Letter: New Sponsor, Same Violative Promotional Practices For Insomnia Drug Doral

 
• By Michael Cipriano
  
WarningSign_1200x675
The FDA sent a warning letter to Galt for allegedly misbranding its insomnia drog Doral.

More from Marketing & Advertising

More from Compliance